For research use only. Not for therapeutic Use.
NMDAR antagonist 1 is a potent and orally bioavailable NR2B-selective NMDAR antagonist[1].<br>NMDAR antagonist 1 (Compound 5q) exhibits excellent neuroprotective activity[1].
NMDAR antagonist 1 can attenuate Ca2+ influx induced by NMDA[1].
NMDAR antagonist 1 can suppress the NR2B up-regulation and increase p-ERK1/2 expression[1].
NMDAR antagonist 1 inhibits SH-SY5Y cells with cell viabilities of 75.8%, 80.0%, 84.4%, and 78.6% at 0.1 µM 1 µM 10 µM 100 µM, respectively[1].
Catalog Number | I009738 |
CAS Number | 2220162-06-9 |
Molecular Formula | C₂₀H₂₀BrN₃O₂ |
Purity | ≥95% |
Reference | [1]. Zhang L, et al. Design, synthesis and bioevaluation of 1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline-1-carboxylic acid derivatives as potent neuroprotective agents. Eur J Med Chem. 2018 May 10;151:27-38. |